tiprankstipranks
Trending News
More News >
Hisamitsu Pharmaceutical Co Inc (JP:4530)
:4530
Japanese Market

Hisamitsu Pharmaceutical Co (4530) Ratios

Compare
2 Followers

Hisamitsu Pharmaceutical Co Ratios

JP:4530's free cash flow for Q1 2026 was ¥0.61. For the 2026 fiscal year, JP:4530's free cash flow was decreased by ¥ and operating cash flow was ¥0.11. See a summary of the company’s cash flow.
Ratios
TTM
Feb 25Feb 24Feb 23Feb 22
Liquidity Ratios
Current Ratio
3.77 4.32 4.22 4.68 6.22
Quick Ratio
3.28 3.84 3.76 4.23 5.71
Cash Ratio
1.96 2.42 2.45 2.87 4.02
Solvency Ratio
0.38 0.44 0.31 0.30 0.29
Operating Cash Flow Ratio
0.00 0.40 0.40 0.30 0.60
Short-Term Operating Cash Flow Coverage
0.00 17.62 16.98 11.88 17.93
Net Current Asset Value
¥ 124.85B¥ 140.12B¥ 132.32B¥ 143.66B¥ 152.20B
Leverage Ratios
Debt-to-Assets Ratio
<0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Equity Ratio
<0.01 0.01 <0.01 <0.01 <0.01
Debt-to-Capital Ratio
<0.01 0.01 <0.01 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
<0.01 <0.01 <0.01 <0.01 <0.01
Financial Leverage Ratio
1.27 1.24 1.24 1.22 1.20
Debt Service Coverage Ratio
24.94 26.34 18.02 15.74 13.02
Interest Coverage Ratio
795.00 821.52 731.50 773.27 466.85
Debt to Market Cap
<0.01 <0.01 <0.01 <0.01 <0.01
Interest Debt Per Share
33.63 52.69 27.54 29.12 30.54
Net Debt to EBITDA
-3.43 -3.16 -4.53 -5.69 -7.33
Profitability Margins
Gross Profit Margin
59.05%58.46%55.73%56.65%58.30%
EBIT Margin
13.85%18.40%13.55%12.57%10.80%
EBITDA Margin
18.13%22.46%17.20%16.43%14.39%
Operating Profit Margin
11.48%12.11%9.29%9.04%7.77%
Pretax Profit Margin
16.10%18.39%13.54%12.56%10.78%
Net Profit Margin
12.55%13.95%9.86%9.15%8.04%
Continuous Operations Profit Margin
12.84%14.30%10.18%9.45%8.21%
Net Income Per EBT
77.95%75.85%72.81%72.87%74.54%
EBT Per EBIT
140.24%151.82%145.71%138.92%138.76%
Return on Assets (ROA)
5.84%6.34%4.25%3.74%3.19%
Return on Equity (ROE)
7.39%7.86%5.27%4.58%3.81%
Return on Capital Employed (ROCE)
6.30%6.39%4.66%4.27%3.45%
Return on Invested Capital (ROIC)
5.01%4.94%3.48%3.20%2.61%
Return on Tangible Assets
5.94%6.45%4.34%3.75%3.20%
Earnings Yield
4.68%7.00%4.64%3.87%3.25%
Efficiency Ratios
Receivables Turnover
3.28 3.30 3.30 3.23 3.15
Payables Turnover
3.80 6.54 6.53 3.73 3.79
Inventory Turnover
2.54 2.89 2.96 2.94 3.05
Fixed Asset Turnover
2.66 2.60 2.86 2.97 3.08
Asset Turnover
0.47 0.45 0.43 0.41 0.40
Working Capital Turnover Ratio
1.10 1.02 0.93 0.79 0.72
Cash Conversion Cycle
159.03 180.78 177.99 139.34 138.94
Days of Sales Outstanding
111.21 110.49 110.71 113.07 115.74
Days of Inventory Outstanding
143.84 126.10 123.20 124.15 119.51
Days of Payables Outstanding
96.01 55.81 55.92 97.88 96.30
Operating Cycle
255.04 236.59 233.92 237.22 235.24
Cash Flow Ratios
Operating Cash Flow Per Share
0.00 254.91 236.46 160.41 236.40
Free Cash Flow Per Share
0.00 67.80 66.98 60.74 184.77
CapEx Per Share
0.00 187.11 169.48 99.67 51.63
Free Cash Flow to Operating Cash Flow
0.00 0.27 0.28 0.38 0.78
Dividend Paid and CapEx Coverage Ratio
0.00 0.92 0.93 0.87 1.74
Capital Expenditure Coverage Ratio
0.00 1.36 1.40 1.61 4.58
Operating Cash Flow Coverage Ratio
0.00 4.87 8.66 5.55 7.80
Operating Cash Flow to Sales Ratio
0.00 0.12 0.13 0.10 0.16
Free Cash Flow Yield
0.00%1.61%1.71%1.59%5.05%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
21.39 14.29 21.57 25.81 30.78
Price-to-Sales (P/S) Ratio
2.66 1.99 2.13 2.36 2.47
Price-to-Book (P/B) Ratio
1.59 1.12 1.14 1.18 1.17
Price-to-Free Cash Flow (P/FCF) Ratio
0.00 62.30 58.50 62.89 19.81
Price-to-Operating Cash Flow Ratio
0.00 16.57 16.57 23.81 15.48
Price-to-Earnings Growth (PEG) Ratio
8.98 0.23 0.95 1.06 6.10
Price-to-Fair Value
1.59 1.12 1.14 1.18 1.17
Enterprise Value Multiple
11.22 5.72 7.84 8.69 9.85
Enterprise Value
324.11B 200.28B 191.01B 183.22B 170.41B
EV to EBITDA
11.22 5.72 7.84 8.69 9.85
EV to Sales
2.04 1.28 1.35 1.43 1.42
EV to Free Cash Flow
0.00 40.13 37.07 38.02 11.36
EV to Operating Cash Flow
0.00 10.67 10.50 14.40 8.88
Tangible Book Value Per Share
3.76K 3.71K 3.38K 3.25K 3.12K
Shareholders’ Equity Per Share
3.80K 3.76K 3.44K 3.23K 3.12K
Tax and Other Ratios
Effective Tax Rate
0.20 0.22 0.25 0.25 0.24
Revenue Per Share
2.25K 2.12K 1.84K 1.62K 1.48K
Net Income Per Share
282.36 295.57 181.61 148.00 118.92
Tax Burden
0.78 0.76 0.73 0.73 0.75
Interest Burden
1.16 1.00 1.00 1.00 1.00
Research & Development to Revenue
0.07 0.07 0.06 0.08 0.09
SG&A to Revenue
-0.17 0.17 0.18 0.18 0.17
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
0.00 0.65 1.30 0.79 1.48
Currency in JPY